Ticarcillin/clavulanate desensitization protocol.
McIntire
L C
LC
Castano
M C
MC
D002675:Child, Preschool; D002969:Clavulanic Acids / Q000276:immunology / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications; D003888:Desensitization, Immunologic; D004359:Drug Therapy, Combination / Q000276:immunology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D011008:Pneumococcal Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013982:Ticarcillin / Q000276:immunology / Q000627:therapeutic use
D002969:Clavulanic Acids; C043215:ticarcillin-clavulanic acid; D013982:Ticarcillin